Peer Review reports
From: EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
| Original Submission | ||
|---|---|---|
| 13 Sep 2020 | Submitted | Original manuscript |
| 9 Oct 2020 | Reviewed | Reviewer Report |
| 12 Oct 2020 | Reviewed | Reviewer Report |
| 16 Nov 2020 | Author responded | Author comments - Zhen Zhang |
| Resubmission - Version 2 | ||
| 16 Nov 2020 | Submitted | Manuscript version 2 |
| 11 Dec 2020 | Reviewed | Reviewer Report |
| 23 Dec 2020 | Reviewed | Reviewer Report |
| 24 Dec 2020 | Author responded | Author comments - Zhen Zhang |
| Resubmission - Version 3 | ||
| 24 Dec 2020 | Submitted | Manuscript version 3 |
| Publishing | ||
| 29 Dec 2020 | Editorially accepted | |
| 2 Feb 2021 | Article published | 10.1186/s12916-020-01899-x |
You can find further information about peer review here.